1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,097 | 0,157 | 09:36 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Neem's Hill AB: Scandinavian ChemoTech AB changes name to Neem's Hill AB | 172 | GlobeNewswire (Europe) | Former Scandinavian ChemoTech AB, has completed the name change to Neem's Hill AB ("Neem's Hill" or "the Company"), which was resolved at the Annual General Meeting held on 5 May 2026. The name change... ► Artikel lesen | |
| Fr | Change of issuer name for Scandinavian ChemoTech AB | 195 | GlobeNewswire | As from July 13, 2026, Scandinavian ChemoTech AB will change issuer name
Company name is Neem's Hill AB.
Old issuer name: Scandinavian ChemoTech AB
New issuer name: Neem's Hill AB
New... ► Artikel lesen | |
| 02.06. | Scandinavian ChemoTech AB: Scandinavian ChemoTech secures SEK 6 million Growth Loan from a larger Swedish Financial Institution | 126 | GlobeNewswire (Europe) | Scandinavian ChemoTech has secured a SEK 6 million growth loan from a larger financial institution in Sweden.
The financing forms part of ChemoTech's long-term financial strategy and will support the... ► Artikel lesen | |
| NEEMS HILL Aktie jetzt für 0€ handeln | |||||
| 28.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim report Q1 2026 | 244 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website January - March 2026
Net sales amounted to 2,798 KSEK (2,472)
Profit/loss after... ► Artikel lesen | |
| 07.04. | Scandinavian ChemoTech AB: ChemoTech's Proposed Strategic Changes Accepted by Nasdaq First North | 166 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) (the "Company") today announces that, based on information disclosed in the Company's press releases published on Tuesday, March 31, ahead of the notice of the Annual... ► Artikel lesen | |
| 01.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Starts 2026 Strong with Best First Quarter in Company History | 190 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care continues its strong commercial momentum, delivering its best first quarter in the company's history in Q1 2026, with sales amounting to approx. 299,000 USD compared... ► Artikel lesen | |
| 31.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech proposes expanded business activities, name change & received proposal on directed issue | 236 | GlobeNewswire (Europe) | NOT FOR DISCLOSURE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND... ► Artikel lesen | |
| 17.02. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-end report 2025 | 260 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
October - December 2025
Net sales amounted to 2,648 KSEK (2,041)
Profit/loss after... ► Artikel lesen | |
| 05.01. | Scandinavian ChemoTech AB: New Year's Letter to Shareholders in Scandinavian ChemoTech - Reflecting on 2025 | 344 | GlobeNewswire (Europe) | Dear Shareholders,
As we enter 2026, I would like to thank you for your continued trust and support of Scandinavian ChemoTech. The past year, 2025, has been an important one for the Company, a year... ► Artikel lesen | |
| 04.11.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025 | 219 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
July - September 2025 ... ► Artikel lesen | |
| 17.10.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide | 232 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed... ► Artikel lesen | |
| 01.10.25 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown | 257 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division is proud to announce another strong quarter, generating sales of USD 340,000 in Q3 2025. This result is within USD 50,000 of the company's record-breaking... ► Artikel lesen | |
| 26.09.25 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion | 604 | GlobeNewswire (Europe) | Scandinavian ChemoTech and its subsidiary VQ Animal Care Inc. is pleased to announce that it has officially started marketing vetIQure, its Tumor Specific Electroporation (TSE) technology in Switzerland.... ► Artikel lesen | |
| 10.09.25 | Scandinavian ChemoTech AB: ChemoTech Expands in Illinois as 8th Clinic within Major U.S. Veterinary Group Adopts TSE Technology | 209 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB today announced that its veterinary subsidiary, VQ Animal Care Inc., has secured a new partnership in Illinois. With this latest order, the eighth clinic within one of the... ► Artikel lesen | |
| 12.08.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025 | 266 | GlobeNewswire (Europe) | Second quarter sales reached 3,841 KSEK, which is the best quarter so far. All sales originated from Animal Care. The report is attached to this press release and can also be downloaded from the company's... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 32,360 | 0,00 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| LIFESTANCE HEALTH GROUP | 10,795 | +0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 28,030 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,350 | +0,11 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 6,290 | +0,16 % | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an | ||
| CLEARPOINT NEURO | 15,960 | 0,00 % | EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery | ||
| PACS GROUP | 44,920 | 0,00 % | Hohes Handelsaufkommen bei Optionen der Pacs Group |
NEEMS HILL AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,127 Euro und damit -28,25 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEEMS HILL AB finden Sie auf Wallstreet Online.